, ,

The Impact of Global Health Equity on Poverty in Kenya

The Impact of Global Health Equity on Poverty in KenyaDespite advances in economic development, millions of Kenyans still live in poverty. In 2022, about 40% of the population lived below the poverty line and at least 32% could not afford an adequate diet. This lack of basic resources prevents many people from living stable, productive lives, despite Kenya’s economic growth. The country has historically faced major health challenges. The prevalence of endemic diseases combined with a lack of access to adequate health care has exacerbated the impact of systemic poverty in Kenya.

Progress Through Global Health Initiatives

Kenya, with a rapidly growing population, is currently home to more than 57 million people. There are still significant social disparities between the rural and urban areas, as 85% of all poor people live in rural areas, while the majority of the urban poor live in slums. Achieving global health equity requires expanding access to clinics, life-saving medicines and trained health professionals.

Over the past two decades, various global health equity initiatives have improved the health landscape in Kenya. The government, supported by international organizations, has focused on preventing and treating infectious diseases like HIV/AIDS. Programs such as PEPFAR (President’s Emergency Plan for AIDS Relief), USAID and the World Health Organization (WHO) expanded access to clinics, medicines and trained professionals. These ongoing efforts have significantly improved health outcomes for citizens, leading to a reduction in poverty in Kenya.

Health Access and Economic Growth

Increased access to health care directly correlates with economic growth. Currently, the Kenyan economy is dominated by agriculture and informal micro-enterprises, which do not provide workers with any health coverage. Workers who cannot afford or access medical care often lose valuable workdays due to illness. Inadequate health care services exacerbate the effects of the epidemic diseases plaguing the nation. The inability to treat these diseases early on leads to increased medical costs. People suffer needlessly, children are too sick to go to school and the nation’s overall well-being and economy are affected, creating a vicious cycle of poverty in Kenya that cannot be stopped without health interventions.

HIV/AIDS: Evolution of Global Health Equity

Kenya’s efforts against HIV/AIDS offer an example of how targeted global health interventions can transform a nation’s future. In the late 1990s, HIV prevalence in Kenya was at an all-time high. By 1997, about 37% of men and 45% of women with a sexually transmitted infection also tested positive for HIV. Societal stigma and the high cost of ART limited access to treatment, while the country’s health care system struggled to manage the growing number of cases. This resulted in high mortality rates and large numbers of orphaned children.

To combat the crisis, international organizations began funding HIV relief efforts in Kenya. Groups such as PEPFAR, the Global Fund and USAID increased access to HIV testing, distributed ART and launched education campaigns. As of 2023, around 1.3 million Kenyans were receiving life-saving antiretroviral therapy.

Productivity Gains and Innovations in HIV Treatment

Modern ART has led to improvements in health and productivity for people living with HIV. A significant benefit has been an increase in the country’s productivity. In two studies focusing on agricultural workers in Kenya, researchers found that workers on ART doubled the number of days they could work each month. Participants also showed a 20% increase in labor force participation and a 35% increase in hours worked. These findings demonstrate the economic value of accessible health interventions.

Dr. Ann Kurth, an epidemiologist and leader in global health systems, spoke with The Borgen Project about Kenya’s progress. “Antiretrovirals came to sub-Saharan Africa and made transformative difference,” she said. “Health system strengthening by PEPFAR funding got you 26 million lives saved. Workforce training helped community health workers screen and test people for HIV in people’s homes with oral tests. We did a lot of self-testing in Kenya. These are innovations that were not the norm, but it helped people identify if they had HIV and get treated earlier.”

Equity and Inclusion in Health Care

Despite many advancements in global health equity in Kenya, significant challenges persist. Rural areas continue to struggle with shortages of medical professionals, transportation barriers and inadequate health care infrastructure. Shifting donor priorities can also affect long-term funding. Dr. Kurth emphasized the need for gender equity in care and research. Historically, clinical trials have underrepresented women and ignored key differences in how diseases and treatments affect them. “Women have not always been represented in clinical trials. A lot of assumptions about clinical practice are based on an assumption of it being a male body. There needs to be more gender representation in research and clinical services and not think of women as just about childbearing.”

Looking Ahead

Kenya’s commitment to improving health care access offers a model for other countries facing poverty. Strategic partnerships with international organizations have saved lives, built community resilience and contributed to reducing poverty in Kenya. Continued investment in health infrastructure, gender-inclusive research and rural outreach could be essential. As Dr. Kurth concluded, “We’ve been able to see major investments in the last couple of decades… That led to incredible child survival, maternal mortality improvements, increases in income and some advances in gender equality.”

– Rafe Photopoulos

Rafe is based in Gainesville, FL, USA and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

Addressing HIV/AIDS in Morocco

HIV/AIDS in MoroccoThe HIV/AIDS epidemic in Morocco has had life-changing consequences for communities all over the world. International leaders have made significant progress over the past 30 years in improving awareness of the disease and accessibility to treatment, but countries must still take substantial action to fully eradicate it. Morocco has taken large strides towards this, launching various campaigns to do so. However, the extreme levels of poverty that the country is facing are forcing its residents into lifestyles that intensify their risk of contracting the disease, while the government’s lack of economic stability means prevention and treatment schemes are difficult to enact. Without U.S. support, the country lacks many resources which would be indispensable to its fight against HIV/AIDS in Morocco.

The Prevalence of HIV/AIDS in Morocco

As of 2024, the number of people living with HIV in Morocco stands at 23,000. About 5.9% of HIV/AIDS cases are men who engage in sexual relationships with other men (MSM), 7.1% are drug users and 2.3% are sex workers. The socio-political climate of Morocco still subjects these populations to extreme levels of discrimination, which often prevents them from seeking treatment. Additionally, 9% of Morocco’s population live currently in poverty. These difficult conditions, alongside the prevalence of sex tourism and human trafficking, mean there are an estimated 4.3 million sex workers living in Morocco, 2.3% of whom (knowingly) suffer from HIV.

The prevalence of drug users is also intertwined with national poverty, with economic stress forcing many to turn to substance abuse as a form of relief. The country’s lack of free health care also stands as a barrier to impoverished individuals accessing diagnoses and treatment, further increasing the risk of infection for those affected. Offering schemes to help alleviate the pressure of national poverty may prevent those it affects from turning to high-risk modes of employment and dangerous drug use, while making treatment accessible to those unable to afford healthcare bills. 

Breaking Down the Stigma

In comparison to other Middle Eastern and North African countries, the rate of HIV/AIDS among the population is relatively low. This is due to Morocco’s unmatched ability in implementing testing, diagnoses and treatment programs within its vulnerable communities. 

Thanks to the introduction of self-testing methods, the population now have access to a more discreet method of diagnosis. However, hospitals must still confirm tests offering positive results, limiting their anonymity and leading to a relatively low use rate.

Morocco’s ban on homosexuality, sex work and injection drugs, alongside general societal disapproval, means that many people who engage in these activities do not attempt to seek treatment for HIV/AIDS. 

In 2024 at the Taragalte Festival, Moroccan artist OUM announced that she would be ascending to the role of National Goodwill Ambassador in Morocco for UNAIDS. As a popular artist and social influencer, OUM’s work in spreading awareness and encouraging education about HIV prevention will be vital in breaking down the intense stigma surrounding the illness. UNAIDS foresaw that OUM’s efforts in erasing negative narratives via her public influence would improve access to HIV/AIDS preventative knowledge, diagnoses and treatment, particularly among high-risk communities in Morocco.

The US’s Impact

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a campaign aimed at controlling the international HIV/AIDS epidemic, does not currently practice in Morocco. This means the country does not have access to U.S. funded resources that could have a significant impact on HIV/AIDS prevention and treatment and, due to the nation’s lower economic status, could not be financed by only their government. PEPFAR supports communities most vulnerable to the illness and with high-risk populations making up the majority of diagnoses in Morocco, the U.S. Department of State’s assistance could offer profound assistance in curbing the epidemic where it is most rife. 

HIV/AIDS in Morocco is preventable. Governmental strategies to combat the disease and its often poverty-rooted causes are already having a profound impact on decreasing its prevalence in the country. However, the epidemic requires further action to achieve total eradication. Reducing societal stigma is an important aspect of making treatment more accessible, but assisting those in poverty, through Moroccan and U.S. funded support, to obtain affordable healthcare schemes and engage in lower-risk lifestyles is by far the most crucial method of ending HIV/AIDS in Morocco for good.

– Amabel Smith

Amabel is based in London, UK and focuses on Global Health for The Borgen Project.

Photo: Unsplash

,

Combating HIV in Ivory Coast

HIV in Ivory CoastIvory Coast, officially the Republic of Côte d’Ivoire, is a country of around 31 million people on the southern coast of West Africa. Though now a sovereign state, Ivory Coast is a former French colony; researchers say former French colonies in West Africa are “where retroviruses first jumped from primates to humans.” While Ivory Coast has made progress in managing the epidemic, the country remains one of the most affected by HIV in West Africa. People in this region are still in dire need of testing, treatment and prevention resources.

Facts About HIV in Ivory Coast

  • Around 2% of people in Ivory Coast are living with HIV. However, a quarter of this population is estimated to be undiagnosed.
  • The Rate of HIV in Ivory Coast has steadily declined within the past decade, declining from 4.5% in 2006 to 2.7% in 2014.
  • Women experience higher rates of HIV than men.
  • There is a high proportion of invasive cervical cancer related to HIV.
  • Sexual transmission is the primary mode of HIV infection. However, transmission through breastfeeding remains a significant issue.
  • Coinfection of HIV with other human retroviruses, such as Human T-lymphotropic virus type 1 (HTLV-1) and hepatitis viruses B, C and delta, is common in Ivory Coast. However, these coinfections are often inadequately managed, with many patients remaining undiagnosed.
  • About 94% of people receiving HIV treatment in Ivory Coast have achieved viral suppression. However, access to testing and treatment remains limited.

What’s Being Done

In efforts to support individuals living with HIV and bolster overall public health, humanitarian organizations and individuals alike have initiated programs in the Ivory Coast to aid the epidemic:

  • The Center for Solidarity and Social Action (CSAS). CSAS was founded in 1995 in Bouaké to promote a better quality of life for people living with HIV, including children and young people. At the time, the organization had the first program dedicated to children and teenagers living with HIV. While the initiative initially offered psychological support, in the present day, CSAS uses medical treatment for patients.

    The organization offers help with the management of STIs, HIV/AIDS screening tests, management of opportunistic infections and access to care and prescriptions. CSAS also leads the PRESERV project, working to improve access to reproductive health and HIV services for young people and vulnerable groups.
  • The Joint United Nations Programme on HIV and AIDS (UNAIDS). UNAIDS, a United Nations (U.N.) organization, was established in 1994 to strengthen responses to HIV epidemics on a systematic scale. It aims to head the global effort to end AIDS as a public health threat by 2030.

In Ivory Coast, the program uses educational initiatives to promote HIV prevention and sexual health to support communities. During the height of the COVID-19 pandemic, UNAIDS partnered with the United Nations Development Programme (UNDP) to provide food and hygiene kits to needy mothers. This partnership seeks to support vulnerable pregnant and breastfeeding women, especially those affected by HIV. This partnership seeks to support vulnerable pregnant and breastfeeding women, especially those affected by HIV.

Challenges remain in the prevention and treatment of HIV in Ivory Coast. Nonetheless, the progress achieved through these initiatives highlights civilian organizations’ impact on crisis response when given sufficient support. A maintained emphasis on education, contraception and access to medical care can be effective ways of continuing to rectify HIV.

– Erin Hellhake

Erin is based in Old Bridge, NJ, USA and focuses on Global Health, Politics for The Borgen Project.

Photo: Pexels

, ,

How USAID Programs in Russia Have Addressed HIV/AIDS and TB

USAID Programs in RussiaAs the U.S. government considers further cuts to international assistance, USAID programs in Russia can show what the U.S. can accomplish when it comes to combating disease and poverty. However, it also can be a cautionary tale of what can happen to a country’s most vulnerable when USAID programs are suddenly cut without an adequate replacement. 

Starting in 1992, after the end of the Cold War and the fall of the Soviet Union, the United States began a robust program of assistance to the new Russian Federation starting with the Freedom Support Act authorizing USAID to begin work in Russia. USAID programs in Russia included initiatives to assist with democratic reform, market assistance, anti-corruption programs, but mostly important disease eradication.

USAID’s Fight Against TB and HIV/AIDS in Russia

USAID programs in Russia fought both tuberculosis and HIV/AIDS. Starting in 1999, USAID began to focus specifically on drug-resistant tuberculosis (TB), which had become a major issue in the former Soviet Union, especially in Russia. According to William B. Taylor, coordinator of U.S. assistance to Newly Independent States, in 1999, USAID was critical to coordinating between Russian authorities, the World Health Organization (WHO) and the Red Cross to combat TB, starting in three provinces and then the rest of Russia. Additionally, USAID also helped provide more than $200 million in critical medical supplies.

By 1999, the spike of TB incidence finally ended and began to decline through the early 2010s. TB mortality rates also declined and experts attributed much of this progress to early detection and prevention programs in Russia. 

Additionally, USAID was instrumental in fighting HIV/AIDS in Russia on several levels; increasing coordination between Russian and American biomedical researchers, assisting with vaccine development, infection prevention, treatment and increasing awareness among Russian business and civic leaders. In 2010, USAID funded the HIV Prevention for At-Risk Populations in Russia program, which treated thousands in the city of Kazan alone.

The Current Situation

According to former U.S. ambassador to Russia, Michael McFaul, “Over the last twenty years, the USAID Mission in Russia has worked with Russian government officials and Russian non-governmental organizations to achieve a remarkable record of success.” However, in 2012, due to rising tensions between the Russian and U.S. governments, Vladimir Putin ordered USAID to cease its operations in Russia.

The Russian government argued that Russian society had moved past the need for external aid. In reality, living conditions in Russia have continued to be extremely difficult. By 2018, Russia became the third-highest country for TB infection, largely due to its inability to follow WHO guidelines.

The Russian Red Cross had to end five different programs dedicated to fighting TB since it received funding from USAID. That being said, thanks to continued funding and cooperation with other international organizations, TB mortality and incidence rate continues to modestly decline, despite setbacks. However, much of the progress in fighting HIV/AIDS in Russia has suffered major reversals. By 2017, Russia had the largest number of HIV-positive individuals in Europe. As of 2024, 30,000 Russians annually are estimated to have died from HIV/AIDS.

Looking Ahead

The history of USAID programs in Russia highlights the danger of suddenly turning off humanitarian aid. In 2025, freezes of USAID funding in places like Ukraine have threatened HIV treatment, endangering more than 116,000 people. However, that history also serves as an encouragement of what is possible with U.S. support.

– Joseph Laughon

Joseph is based in Sacramento, CA, USA and focuses on Good News for The Borgen Project.

Photo: Wikipedia Commons

, ,

The Decline of HIV/AIDs in Myanmar

HIVAIDs in MyanmarMyanmar, formerly known as Burma, is one of 35 countries where 90% of HIV infections occur worldwide. As of 2017, the World Health Organization (WHO) found that Myanmar accounted for 224,026 HIV/AIDS cases, or 0.54% globally. This, though still considered prevalent, has declined at a steady pace. The new efforts began in 2016, with tremendous success resulting in the current year to lessen the effects of HIV/AIDS in Myanmar.

What Is Going On?

Myanmar has experienced ongoing civil conflict since gaining independence from British rule in 1948, with numerous constitutional changes ultimately leading to the establishment of a military-led (Junta) state. In 2021, the country descended into full-blown civil war after the military disputed the results of a general election in which the National League for Democracy won a majority. Claiming electoral fraud, the military carried out a coup, detaining elected leaders and seizing control of the government. Since then, the conflict has escalated and continues to this day.

The majority of Myanmar’s citizens support the pro-democracy resistance against the Junta, and that support has made an impact. Despite initiating the conflict, the military has gradually lost ground to opposition forces.

Poverty Rates

Before the civil conflict, Myanmar had a small but growing middle class, and the economy experienced rapid growth throughout the 20th century. However, in the 21st century, shifting government policies and international sanctions slowed this progress. Poverty is growing at an alarming rate. Today, nearly half of the Burmese population lives below the poverty line. This sharp rise in poverty has directly contributed to a range of serious health issues across the country. On top of these challenges, Myanmar follows an “out-of-pocket” healthcare system, which means individuals must cover their medical expenses themselves, making it even harder for those living in poverty to access the care they need.

Because the country is experiencing division and conflict, it has become nearly impossible for many Burmese people to afford or access proper health care. The ongoing unrest has made it even harder for everyday citizens to get the medical help they need. This shows just how urgent the need is for support, whether from the government or international aid organizations. While HIV/AIDS is already a serious health issue in Myanmar, it is not the only one. As poverty increases and the civil crisis continues, more and more diseases are beginning to spread, putting vulnerable communities at even greater risk.

What Is Stopping the End of HIV/AIDS in Myanmar?

Among those infected, 41% are female sex workers, 31% are queer men and 28% are people who inject drugs. Because of the criminalization of sex work, homosexuality and drug usage, many people with HIV/AIDS are scared to accept treatment. The Aids Datahub found that 7% of individuals who avoided going to treatment clinics were scared of punishment and the stigma surrounding HIV/AIDS.

If a person is found “guilty” of homosexuality, they can be sentenced to up to 10 years of prison. An individual found guilty of soliciting can serve up to 6 years in prison. Lastly, Myanmar is the leading source of opium and heroin, two injectable substances. The United Nations Office on Drugs and Crime (UNODC) predicts that up to 90,000 Burmese people inject drugs, or about 0.23%.

The UNODC has also found that overall drug use has declined steadily from 2020 to 2024. Programs that are working to limit drug use or encourage “safer” drug use in high usage areas in Southeast Asian countries (Myanmar, China and Bangladesh) are helping to reduce the usage of injectable drugs and the number of new HIV/AIDS infections in Myanmar.

What Is Going Right?

This downward trend is largely due to a renewed national HIV response strategy launched in 2016. These efforts focused on expanding access to antiretroviral therapy (ART), improving testing and counseling services and targeting high-risk populations through community-based outreach. By 2023, more than three-quarters of people living with HIV in Myanmar were receiving treatment, marking a major public health achievement despite ongoing political and social challenges.

Despite civil war breaking out in 2021, efforts to maintain access to antiretroviral treatment to minimize HIV/AIDS in Myanmar remain strong. According to the AIDS Data Hub, new infections have declined to fewer than 10,000 per year. Of the 280,000 suspected cases, 216,757 have been confirmed. All confirmed individuals are receiving antiretroviral therapy (ART).

Beginning in July 2020, Myanmar introduced Pre-Exposure Prophylaxis (PrEP), where people routinely take ART to reduce the chances of getting HIV. It is still implementing this preventative measure today. Many foreign aid programs, such as USAID, the Global Fund and the National AIDS program, are funding access to PrEP.

What to Takeaway?

Despite ongoing conflict and growing poverty within the country, national and international efforts to curb the spread of HIV/AIDS in Myanmar remain strong. The number of new infections continues to decline annually, bringing the country closer to the global 2030 goal of eliminating new HIV cases. Access to treatment has significantly improved, with antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) available to all individuals who seek it, regardless of background or risk group. 

– Abby Buchan

Abby is based in York, PA, USA and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

The Fight Against HIV/AIDS in Fiji 

HIVAIDS in FijiFiji, an archipelago made up of 300 islands and 540 islets in the Pacific Ocean, has declared an HIV outbreak after the alarming spike in cases over the last few years. According to experts, “since the first reported case in 1989, HIV-1 incidence in Fiji has increased by about tenfold, from 0.7 per 100,000 in 2000 to 7 per 100,000 in 2021. While this increase is largely due to improved diagnostic capacity, it is also suspected to reflect a growing epidemic.” Here is more information about HIV/AIDS in Fiji.

Causes

The Fijian Health Ministry credits the rise in HIV/AIDS cases in Fiji to illegal drug usage. There are two particular practices that are said to have caused the spike in cases, which are “bluetoothing” and “chem-sex.” However, others believe that the rise of cases is due to the lack of funding and research in HIV/AIDS as a whole. According to an EastAsiaForum article, “before 2012, they used a combination prevention approach to HIV. Funding had ramped up in 2008 through the HIV and STIs Regional Response Fund… [but] in 2013, the HIV Regional Response funding ended.” This may have played a significant role in the spike of HIV/AIDS cases in the Fijian Islands. 

Financial Implications

The HIV/AIDS outbreak has not only severely impacted the health of Fijians but also their finances and quality of life. Fiji’s increasing rates of urbanization, which have caused homelessness and unemployment, have also contributed to the HIV/AIDS epidemic in Fiji. Additionally, a large part of Fiji’s economy is reliant upon tourism, as they are still recovering from COVID-19. A reputation hit that could come from this outbreak would be detrimental to the Fijian economy, which would likely make the spread even worse, as it is disproportionately affecting those who are economically struggling.

Responses to the Spike

In January 2025, Fiji announced a 90-day containment plan that will guide the nation’s AIDS response until 2027. This is the start of the prioritization of HIV research in Fiji and helping the most vulnerable among the population get the treatment they need. However, there is still the underlying concern that some people who are HIV positive in Fiji are not aware of their status, and those who are too afraid to receive the care that they need due to prejudice and the stigmatization of the condition. Minister Lalabalavu, the minister of Health and Medical Services of Fiji, says that “discrimination and stigma will only serve to make our current situation worse.”

In order to combat this, there are many movements to increase education on HIV/AIDS in hopes of increasing knowledge and reducing stigma, such as the HIV Surge Strategy 2024-2027 that the Fijian government has endorsed. The focus of the strategy is based on intersecting issues that contribute to the rise in HIV cases, such as prevention, treatment, harm reduction, human rights and social justice. Additionally, it plans on coordinating public health responses due to the presence of hard drugs within the Fijian community.

Government Intervention

UNAIDS Deputy Executive Director Jan Beagle said, “The most effective results can only be achieved through partnership across sectors, through strong leadership, and with community at the center. By taking AIDS out of isolation, the impact can go far beyond the AIDS response.” Displaying that this issue has become a government issue, and due to this the government has given Fijian $FJ200,000 for its HIV/AIDS Prevention and Control Programme, a program that targets the prevention of drug use in underprivileged communities as well as destigmatizing testing centers and HIV itself, in the 2023-2024 budget and is only adding more every year to combat this crisis.

Looking Ahead

While the outbreak of HIV/AIDS in Fiji has extremely affected the country’s population, the increasing awareness towards this issue has allowed them to fight back and take control over their health. However, it is still important to continue raising awareness towards this topic. HIV/AIDS disproportionately affects Fijians that come from low-income communities, and the lack of knowledge has made the spread worse. Therefore, continued efforts are essential to ensuring that these people get the education and support they need to slow the spread. 

– Sydney Carr

Sydney is based in San Diego, CA, USA and focuses on Global Health for The Borgen Project.

Photo: Unsplash

, ,

Mobile Clinics in Kenya Bring Health Care to the Masai Village

Mobile medical care in kenyaLocated on the east coast of Africa, Kenya is a country of mountains, lakes, savannahs and the Great Rift Valley. With more than 50 million people, Kenya is expected to see a 51% population increase in the next 25 years. Despite this steady growth, the country’s life expectancy remains 66 years—about five years below the global average. HIV/AIDS and tuberculosis are the leading causes of death in Kenya. To curb the spread of these diseases, local governments and organizations have introduced mobile medical care to improve access to health screenings, treatments and health care services.

Targeting HIV/AIDS

A global health issue, the human immunodeficiency virus (HIV) is a virus that attacks the body’s immune system, with acquired immunodeficiency syndrome (AIDS) occurring when the virus advances. More than 40 million people have died of HIV/AIDS globally.

In August 2024, the Military Health and Research Program (MHRP) reported collaborating with local government entities to bring HIV preventative measures and treatment to Masai village in Kenya’s South Rift Valley Region. To bring care to this rural area, the MHRP developed a mobile clinic that could get health care to those who could not access it otherwise.

Utilizing funding from the United States of America’s President’s Emergency Plan for AIDS Relief (PEPFAR), the mobile clinic in Kenya provides patients with HIV testing, preventative education and antiretroviral therapies for those who test positive.

Fighting Tuberculosis

In addition to providing HIV/AIDS treatment, mobile clinics in Kenya also focus on tuberculosis, the leading cause of death among men in the country. This infectious, airborne disease claimed more than one million lives in 2023 alone. Babies, children, malnourished individuals and people with diabetes face a higher risk of contracting tuberculosis. While the disease is both preventable and treatable, many lack access to education about prevention and treatment. Mobile clinics in Kenya are working to bridge this gap and improve health care access.

Before the arrival of the mobile clinic in Masai village, individuals infected with tuberculosis were treated in Tanzania, where there were no closer resources. The MHRP reports that treatment took six months and if an individual died in Tanzania, they were left there. Since the mobile clinic arrived, Masai village had seen no tuberculosis-related deaths for more than a year at the time of the report.

Maurice’s Account

In 2023, the Henry M. Jackson Foundation Medical Research International (HJFMRI) spoke to an individual from Masai village. Maurice, the individual living in the town, acknowledges the benefits of mobile clinics. He explains to HJFMRI that those sent to Tanzania for treatment before the mobile clinics had to walk there on an eight-day trek. Maurice says he and the others from his village are “so happy” and “grateful” for the PEPFAR initiative that allowed the mobile clinics.

Beyond Masai Village

Mobile clinics in Kenya extend well beyond Masai village. CURE, Kenya’s children’s hospital, operates multiple mobile clinics nationwide, bringing health care directly to people where they “work, live and play.” Mobile clinics give health care access to individuals who otherwise have little to none. With funding from PEPFAR and the efforts of MHRP, local governments and other private agencies, mobile clinics bring care to many people in Kenya and work to combat the global health issues of HIV/AIDS and tuberculosis.

– Hannah Pacheco

Hannah is based in Boston, MA, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

HIV/AIDS In Panama: Political Actions and Awareness

HIV/AIDS In Panama: Political Actions and AwarenessIn Panama, approximately 30,000 people are living with HIV/AIDS, with numbers increasing each year. The rise reflects improved testing and awareness, allowing more people to seek and receive the care they had long been without. However, poverty remains a major barrier, particularly among Indigenous communities, where extreme living conditions increase vulnerability to the disease.

Poverty in Panama

Poverty significantly influences both the spread of HIV and access to treatment. While Panama’s overall poverty rate stands at 22%, the impact is disproportionately severe in nonurban areas, where 76% of Indigenous people live in poverty. This stark contrast highlights the need for targeted support, as many Panamanians, particularly in remote regions, still lack essential resources.

The Intersection of Poverty and HIV/AIDS

Economic hardship often results in limited access to hygiene products, including affordable condoms, increasing the risk of HIV transmission. Those infected face further challenges in accessing life-saving medical treatment.  The adult HIV prevalence rate in Panama stands at 1.0% and the country reports nearly 1,000 AIDS-related deaths annually. In the Ngäbe-Buglé territory, AIDS is the leading cause of death, accounting for more than 7% of fatalities, according to Panama’s National Statistics Institute. This intersection of poverty and health disparities highlights the urgent need for comprehensive strategies, including targeted education, expanded health care access and culturally sensitive prevention efforts to curb the spread of HIV/AIDS in Panama.

Political Action Driving Change

Panama began addressing the HIV epidemic in 1985 by offering testing and treatment services. In the early 2000s, the government passed legislation requiring agencies to provide both material and financial support to combat HIV/AIDS. Initially, the national budget focused solely on treatment medication. However, in response to the evolving epidemic, Panama expanded its funding to include public education initiatives. The passing of General Law 3 on STIs in 2000 marked a significant step forward, aiming to prevent discrimination and ensure equitable access to HIV-related services. By 2005, Panama had allocated approximately $10 million from the federal budget toward HIV/AIDS prevention, treatment and awareness campaigns.

Raising Awareness and Reducing Stigma

While increased funding has improved access to treatment, stigma remains a significant obstacle, particularly within Indigenous communities. Misconceptions about HIV/AIDS continue to fuel discrimination, preventing many from seeking testing and care. Public education campaigns have played a crucial role in dispelling myths and fostering a more informed society. These initiatives not only teach people how HIV spreads but also promote understanding and compassion for those affected by the virus. Expanding educational resources to Indigenous regions remains a priority, as these communities face the highest rates of both poverty and HIV/AIDS.

Looking Ahead

The combination of political action, increased awareness and targeted support has allowed Panama to make meaningful progress in addressing HIV/AIDS. However, continued efforts are needed to ensure that vulnerable populations—particularly Indigenous communities—have equitable access to education, prevention tools and medical care. By prioritizing both policy-driven solutions and grassroots awareness initiatives, Panama can continue to bridge the gap between poverty and health, creating a safer, healthier future for all its citizens.

– Kaleb Monteith

Kaleb s based in Greeley, CO, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

HIV/AIDS in Paraguay: UNAIDS at the Forefront of the Response

HIV/AIDS in ParaguayHIV/AIDS left 7,000 children as orphans in Paraguay in 2023 alone. Natanael, an HIV-positive boy living in Paraguay, became an orphan after his mother died of HIV.

What Is HIV?

The human immunodeficiency virus (HIV) is an illness that affects a person’s white blood cells, specifically ones called CD4 cells, that are responsible for immune function. HIV is transmitted through the exchange of bodily fluids. 

Methods of preventing the virus includes using a condom, avoiding used or unclean needles, getting tested regularly, and in some cases, preexposure prophylaxis (PrEP). Treatment for HIV/AIDS involves antiretroviral therapy (ART). 

HIV/AIDS in Paraguay

Despite there being both preventative measures and treatments, HIV/AIDS is an epidemic that continues to burden many parts of the globe. In Paraguay, at least 22,000 people are currently living with HIV/AIDS. Of that number, about half are receiving ART for HIV/AIDS, meaning at least 10,000 are going without life-saving treatment.

HIV/AIDS is concentrated both geographically and among populations in Paraguay. Greater than 75% of those infected with HIV live in the country’s capital, Asunción, with the total number of nationwide cases rising each year. HIV/AIDS is also more prevalent among men who have sex with men (MSM) and sex workers.

Natanael, a young boy living with HIV in Paraguay, became an orphan when his mother died of the virus. Natanael’s mother contracted the illness at her work at a children’s home for kids with HIV, where she and her son also lived.

After her passing, Natanael became an orphan and had to continue living in the home without his mother, because his own family rejected him and his mother after discovering that they were diagnosed with HIV.

UNAIDS Response

To bring aid to people like Natanael, The United Nations has a Joint Programme called UNAIDS. UNAIDS is a global health effort that aims to address HIV/AIDS as a public health crisis. 

As a result, HIV/AIDS in Paraguay and other countries may begin to see a decline as the Joint Team successfully implements different health services throughout the country.

With a program expenditure of $425,483 USD in 2022-2023, UNAIDS was able to: 

  • Provide nearly 550,000 students in Paraguay with comprehensive sex education. 
  • Provide more than 15,000 people in uniform with information regarding HIV/AIDS.
  • Provide more than 5,000 people in Paraguay’s armed forces with rapid HIV and syphilis testing services.
  • Distribute nearly 11,000 condoms throughout the country to prevent the transmission of HIV/AIDS, and other STIs.

The Future

Looking to the future, UNAIDS hopes not only to continue to meet their 90-90-90 goal – 90% of those with HIV are diagnosed, 90% of those diagnosed are treated with ART and 90% of those on ART become virally suppressed — but have targets of 95-95-95.

UNAIDS in Paraguay has worked not only to achieve its 95-95-95 goal but to prevent HIV/AIDS altogether through comprehensive sex education for students and the distribution of condoms throughout the country.

Without education or awareness of HIV, the couple who fell in love with Natanael may have never felt prepared to adopt him. At 12 years old, Natanael finally met his new parents. He was able to go to a loving home and maintain his HIV treatment. 

Other initiatives, such as SOS Children’s Villages, work to provide stable and nurturing homes to children around the globe living in poverty and other extreme situations. Anyone can donate or sponsor a child living in Paraguay, and help them gain access to medical care, food, clothes and love. 

Looking Ahead

HIV/AIDS is a global epidemic. The efforts of UNAIDS in Paraguay since 2022 have expanded public awareness of HIV and its transmission, provided HIV self-testing programs in key areas, and provided health services and information to those in uniform. Efforts such as these are at the forefront of the HIV/AIDS response and should help to decrease the number of cases in the future. 

– Hannah Pacheco

Hannah is based in Boston, MA, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

Methods of Treatment and Testing for HIV/AIDS in Italy 

HIV/AIDS in ItalyHIV/AIDS infection and treatment are consistent concerns that health organizations in Italy are levying. Since high infection numbers in the early 21st century, rates of diagnoses have decreased from 3,858 in 2013 to 1,888 in 2022 according to WHO. Still, the health risk of the disease remains prevalent. Poverty can be an obstacle for seeking diagnosis and treatment for HIV/AIDS in Italy. Universal health services provide a great resource for those experiencing poverty. Currently, hospitals and health organizations in Italy are developing programs to make this impact more wide-spread.

The Ministry of Health and other national organizations are working towards spreading awareness, providing testing and developing medication. They hope to eliminate the possibility of HIV infection altogether. Many institutions have created goals which aim to reduce the number of new diagnoses and provide equitable treatment and counseling to all residents of Italy, regardless of their financial situation.

Injective PrEP Could Prevent HIV/AIDS in Italy

In December 2024, The National Institute for Infectious Diseases (IRCCS) and the Regional Hospital of Lombardy (ASST) collaborated on a solution-oriented program. Authorities in health spoke about emerging technologies at the national health conference, “Long-Acting Retrovirals–looking to the future.” The goal is to investigate and approve PrEP (pre-exposure prophylaxis) as a preventative measure against HIV/AIDS in Italy. Currently, the only available form of PrEP is the once-daily pill.

PrEP is a medication that reduces the risk of contracting HIV when individuals who are at-risk for infection take it. In the United States, the FDA has approved both the oral and long-acting injective forms of PrEP. 

The Italian initiative will provide controlled access to the injective method for 800 individuals and monitor their response. These health servicers wish to provide an alternative to at-risk people who have difficulty accessing or using the oral method. Injective PrEP allows for longer periods between intake compared to the daily oral method. 

“Three Times Zero” 

To commemorate International Day Against AIDS in Italy (December 1, 2024), IRCCS held a health conference. Many Italian changemakers attended including the Minister of Health, Orazio Schillaci, and the Director General of Health of the Lazio Region, Andrea Urbani. 

IRCCS aims to promote the goal of “three times zero against HIV: zero risk of transmission, zero diagnoses and deaths, zero stigma and discrimination.” Powerful entities such as the Italian Red Cross signed the protocol. It sets the precedent for advances in prevention and treatment. It also addresses the marginalization that those with HIV in Italy experience. 

Likewise, this protocol acknowledges the groups of Italian residents facing a disproportionate risk of contracting HIV. This includes men who have sex with men, foreign-born migrants and injective drug users. 

The DiMePReJ (Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area) found that individuals living in marginalized conditions have higher rates of infection. Risk factors include “financial difficulties and lack of secure housing.”

UNAIDS argues that the fight against HIV/AIDS cannot succeed without upholding the human rights of those suffering from the disease.  

Free Testing for HIV/AIDS in Italy

Accessible testing and education are vital to the reduction of HIV infections, especially among marginalized communities. Many free and readily accessible testing methods are available in major cities of Italy. “Let’s do it quick” (facciamolo rapido) launched in 2017 to provide an alternative to the typical blood test for HIV and HCV. This innovative test offers results by testing the saliva, removing the risk of blood contamination among health workers. 

This program supplements “room 13” (stanza 13) at IRCCS in Rome. The institute offers blood tests for HIV and Syphilis at no cost with same-day results. It also provides free counseling for those seeking preventive measures or treatment information. Search engines are readily available online for residents to locate their closest testing and counseling facility.

Vaccine Development

New developments are on the horizon. The Higher Institute of Health (ISS) in Italy partnered with the European HIV Alliance in 2016 to support its development of an HIV vaccine. The EU’s Horizon 2020 Research and Innovation program provided funding for their work. The alliance hoped to develop two new prophylactic vaccine candidates for clinical development using a multidisciplinary vaccine platform (MVP) and further identify scientific basis for continued research. 

Although the alliance has concluded, clinical trials for their vaccine, “EHVA P01” continued. Trials concluded at the end of 2024 with pending results. Scientists aimed to test the efficacy of a vaccine for HIV-uninfected adults. A preventative vaccine for HIV in Italy could reduce infection rates by large margins.

Global Collaboration Against HIV/AIDS

Still, many trials for preventative and therapeutic HIV vaccines are ongoing. Italy is one actor in an international mission to reduce–and eventually eliminate–the risk of infection for HIV. Health authorities are employing both preventative and therapeutic measures to address at-risk and infected individuals. Programs like “Three Times Zero” are reducing the stigma surrounding the disease and those who carry it. National hospitals, like IRCCS, have the potential to close the infection gap between income and population groups by continuing to provide free and accessible health services. Scientific collaboration in Italy has led to emerging treatments that indicate an HIV-free future.

– Sarah Lang

Sarah is based in Pittsburgh, PA, USA and focuses on Technology and Politics for The Borgen Project.

Photo: Pexels